Physician profile
Lora Melman
NPI 1689792525
$24,164.51
in general payments reported to CMS, 2019-2025
14 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,217 · 2020: $1,129 · 2021: $467 · 2022: $806 · 2023: $803 · 2024: $2,023 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $4,130 · Food and Beverage: $1,184 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,214.73 |
| Travel and Lodging | $4,130.34 |
| Food and Beverage | $1,184.23 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $15,413.63 | 2025 | |
| Medical Device Business Services, INC. | $2,119.80 | 2025 | |
| Intuitive Surgical, INC. | $1,914.54 | 2019-2023 | Da Vinci Surgical System |
| Becton, Dickinson and Company | $1,535.53 | 2024 | Phasix Mesh |
| Davol INC. | $1,265.87 | 2019-2024 | Phasix Mesh |
| Ethicon US, LLC | $696.03 | 2019-2025 | Echelon; Endopath, Echelon Flex, Enseal X1 |
| C. R. Bard, INC. & Subsidiaries | $598.35 | 2019 | |
| Medtronic, INC. | $185.13 | 2022-2023 | Endoflip |
| Stryker Corporation | $156.21 | 2021 | |
| Novo Nordisk INC | $154.51 | 2021-2025 | Wegovy |
| Reshape Lifesciences INC. | $48.80 | 2023 | |
| Edwards Lifesciences Corporation | $33.32 | 2021 | |
| Allergan, INC. | $28.17 | 2022 | |
| Endo Pharmaceuticals INC. | $14.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Melman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.